Pathfinder Cell Therapy - Dividend History | PFND
Historical dividend payout and yield for Pathfinder Cell Therapy (PFND) since 1971. The current TTM dividend payout for Pathfinder Cell Therapy (PFND) as of December 31, 1969 is $0.00. The current dividend yield for Pathfinder Cell Therapy as of December 31, 1969 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.000B |
$0.000B |
|
Pathfinder Cell Therapy, Inc. develops cell-based therapy for the treatment of diabetes, renal disease, myocardial infarction, and other diseases characterized by organ-specific cell damage. The Company focuses on its newly discovered mammalian cell type, which is able to stimulate damaged tissues to regenerate without the Pathfinder Cells themselves being incorporated into the new tissue. Pathfinder Cell Therapy, Inc., formerly known as SyntheMed, Inc., is based in Cambridge, Massachusetts.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
